{"sourcedb":"DevicePMAs@therightstef","sourceid":"P920004_S006","text":"Approval for a change to the indications for use to include sue of vasoseal(r) following stent implantation.  The vasoseal(r) vascular hemostasis device is now indicated for use in reducing tiem to hemostasis at the femoral arterial puncture site and in reducing time to ambulation in patients who have undergone diagnostic angiography, balloon angioplasty or stent procedures using an 8 french or smaller procedural sheath and using a retrograde approach.  The vasoseal(r) vhd is also indicated for use in reducing time to hemostasis in balloon angioplasty and stent patients when immediate shealth removal is desired.  However, early ambulation in these patients has not been demonstrated.","project":"consensus_PMA_Age_Indications"}